286 related articles for article (PubMed ID: 34178837)
1. The efficacy and safety profile of capsaicin 8% patch versus 5% Lidocaine patch in patients with diabetic peripheral neuropathic pain: a randomized, placebo-controlled study of south Asian male patients.
Hussain N; Said ASA; Javaid FA; Al Haddad AHI; Anwar M; Khan Z; Abu-Mellal A
J Diabetes Metab Disord; 2021 Jun; 20(1):271-278. PubMed ID: 34178837
[TBL] [Abstract][Full Text] [Related]
2. Topical capsaicin (high concentration) for chronic neuropathic pain in adults.
Derry S; Sven-Rice A; Cole P; Tan T; Moore RA
Cochrane Database Syst Rev; 2013 Feb; (2):CD007393. PubMed ID: 23450576
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study.
Mankowski C; Poole CD; Ernault E; Thomas R; Berni E; Currie CJ; Treadwell C; Calvo JI; Plastira C; Zafeiropoulou E; Odeyemi I
BMC Neurol; 2017 Apr; 17(1):80. PubMed ID: 28431564
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial.
Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
Clin Drug Investig; 2009; 29(4):231-41. PubMed ID: 19301937
[TBL] [Abstract][Full Text] [Related]
5. Capsaicin 8% Patch in Painful Diabetic Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Study.
Simpson DM; Robinson-Papp J; Van J; Stoker M; Jacobs H; Snijder RJ; Schregardus DS; Long SK; Lambourg B; Katz N
J Pain; 2017 Jan; 18(1):42-53. PubMed ID: 27746370
[TBL] [Abstract][Full Text] [Related]
6. Is the Capsaicin 179 mg (8% w/w) Cutaneous Patch an Appropriate Treatment Option for Older Patients with Peripheral Neuropathic Pain?
Pickering G; Engelen S; Stupar M; Ganry H; Eerdekens M
J Pain Res; 2024; 17():1327-1344. PubMed ID: 38560405
[TBL] [Abstract][Full Text] [Related]
7. 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study.
Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
Curr Med Res Opin; 2009 Jul; 25(7):1663-76. PubMed ID: 19485723
[TBL] [Abstract][Full Text] [Related]
8. Tolerability of the capsaicin 8% patch following pretreatment with lidocaine or tramadol in patients with peripheral neuropathic pain: a multicentre, randomized, assessor-blinded study.
Jensen TS; Høye K; Fricová J; Vanelderen P; Ernault E; Siciliano T; Marques S
Eur J Pain; 2014 Oct; 18(9):1240-7. PubMed ID: 24664539
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy.
Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
Curr Med Res Opin; 2009 Jul; 25(7):1677-87. PubMed ID: 19480610
[TBL] [Abstract][Full Text] [Related]
10. Capsaicin 8% patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy: a randomised, 52-week, open-label, safety study.
Vinik AI; Perrot S; Vinik EJ; Pazdera L; Jacobs H; Stoker M; Long SK; Snijder RJ; van der Stoep M; Ortega E; Katz N
BMC Neurol; 2016 Dec; 16(1):251. PubMed ID: 27919222
[TBL] [Abstract][Full Text] [Related]
11. Progressive Response to Repeat Application of Capsaicin 179 mg (8% w/w) Cutaneous Patch in Peripheral Neuropathic Pain: Comprehensive New Analysis and Clinical Implications.
Freynhagen R; Argoff C; Eerdekens M; Engelen S; Perrot S
Pain Med; 2021 Oct; 22(10):2324-2336. PubMed ID: 33871648
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the lidocaine patch 5% vs naproxen 500 mg twice daily for the relief of pain associated with carpal tunnel syndrome: a 6-week, randomized, parallel-group study.
Nalamachu S; Crockett RS; Gammaitoni AR; Gould EM
MedGenMed; 2006 Aug; 8(3):33. PubMed ID: 17406167
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of 0.625% and 1.25% Capsaicin Patch in Peripheral Neuropathic Pain: Multi-Center, Randomized, and Semi-Double Blind Controlled Study.
Moon JY; Lee PB; Kim YC; Lee SC; Nahm FS; Choi E
Pain Physician; 2017 Feb; 20(2):27-35. PubMed ID: 28158151
[TBL] [Abstract][Full Text] [Related]
14. Reversing painful and non-painful diabetic neuropathy with the capsaicin 8% patch: Clinical evidence for pain relief and restoration of function
Anand P; Privitera R; Donatien P; Fadavi H; Tesfaye S; Bravis V; Misra VP
Front Neurol; 2022; 13():998904. PubMed ID: 36388188
[TBL] [Abstract][Full Text] [Related]
15. 8% Capsaicin Patch in Treatment of Peripheral Neuropathic Pain.
Goncalves D; Rebelo V; Barbosa P; Gomes A
Pain Physician; 2020 Sep; 23(5):E541-E548. PubMed ID: 32967405
[TBL] [Abstract][Full Text] [Related]
16. Adhesive capsaicin 8% patch for improved control of pain caused by chemotherapy-induced peripheral neuropathy in patients with multiple myeloma: A single-centre, seven-case series.
Moreno-Alonso D; Llorens-Torromé S; Corcoy de Febrer B; Amandi García M; Serrano-Bermúdez G; Trelis-Navarro J; Mayoral-Rojals V; Serrano-Afonso A
J Oncol Pharm Pract; 2024 Jun; 30(4):752-758. PubMed ID: 38415287
[TBL] [Abstract][Full Text] [Related]
17. Tolerability of NGX-4010, a capsaicin 8% patch, in conjunction with three topical anesthetic formulations for the treatment of neuropathic pain.
Webster LR; Peppin JF; Murphy FT; Tobias JK; Vanhove GF
J Pain Res; 2012; 5():7-13. PubMed ID: 22328830
[TBL] [Abstract][Full Text] [Related]
18. Gabapentin for chronic neuropathic pain in adults.
Wiffen PJ; Derry S; Bell RF; Rice AS; Tölle TR; Phillips T; Moore RA
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007938. PubMed ID: 28597471
[TBL] [Abstract][Full Text] [Related]
19. Treatment of painful radiculopathies with capsaicin 8% cutaneous patch.
Baron R; Treede RD; Birklein F; Cegla T; Freynhagen R; Heskamp ML; Kern KU; Maier C; Rolke R; Seddigh S; Sommer C; Ständer S; Maihöfner C
Curr Med Res Opin; 2017 Aug; 33(8):1401-1411. PubMed ID: 28436279
[TBL] [Abstract][Full Text] [Related]
20. Tolerability of NGX-4010, a capsaicin 8% dermal patch, following pretreatment with lidocaine 2.5%/prilocaine 2.5% cream in patients with post-herpetic neuralgia.
Webster LR; Nunez M; Tark MD; Dunteman ED; Lu B; Tobias JK; Vanhove GF
BMC Anesthesiol; 2011 Dec; 11():25. PubMed ID: 22182397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
